Form 4: Emergent BioSolutions Director Zsolt Harsanyi Receives Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Zsolt Harsanyi received stock options and restricted stock units (RSUs) from Emergent BioSolutions on April 30, 2025, as part of the company's stock incentive plan.

Summary

  • Zsolt Harsanyi, a director at Emergent BioSolutions Inc., received an annual grant of 34,403 restricted stock units (RSUs) on April 30, 2025.
  • These RSUs will vest on the day prior to the one-year anniversary of the grant date, contingent on Harsanyi remaining on the board.
  • Harsanyi also received 15,824 stock options with an exercise price of $5.45, which also vest on the same date, subject to continued board service.
  • The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.
  • Following these transactions, Harsanyi directly owns 123,732 shares of Emergent BioSolutions common stock and 41,572 derivative securities.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice for a company director, indicating stability and alignment of interests. It's a neutral event with a slightly positive undertone due to the incentive structure.

Positives

  • The grant of RSUs and stock options aligns the director's interests with those of the shareholders.
  • The vesting requirements incentivize continued service on the board.

Future Outlook

The RSUs and stock options will vest on the day prior to the one-year anniversary of the grant date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.

Industry Context

Granting stock options and RSUs to board members is a common practice to align their interests with those of the shareholders and incentivize long-term value creation. The specific terms of the grant, such as the vesting schedule and exercise price, are typical for director compensation packages.

Comparison to Industry Standards

  • Director compensation packages often include a mix of cash, stock options, and restricted stock units.
  • The vesting schedules are generally structured to incentivize long-term commitment and alignment with shareholder value.
  • The specific amounts and terms vary depending on the company's size, industry, and performance.

Stakeholder Impact

  • The grant of equity to a director aligns their interests with those of shareholders.
  • This incentivizes the director to make decisions that increase shareholder value.

Key Dates

DateDescription
04/30/2025Date of transaction: Grant of restricted stock units and stock options.
04/29/2032Expiration date of the stock options.

Keywords

Emergent BioSolutions, Director Compensation, Stock Options, Restricted Stock Units, RSUs, Form 4, Beneficial Ownership, Zsolt Harsanyi

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.